OBJECTIVES: Develop and test a theoretical acceptability model for the Nestorone®/ethinyl estradiol contraceptive vaginal ring (CVR); explore whether domains of use within the model predict satisfaction, method adherence and CVR continuation. STUDY DESIGN: Four domains of use were considered relative to outcome markers of acceptability, that is, method satisfaction, adherence and continuation. A questionnaire to evaluate subjects' experiences relative to the domains, their satisfaction (Likert scale) and adherence to instructions for use was developed and administered to 1036 women enrolled in a 13-cycle Phase 3 trial. Method continuation was documented from the trial database. Stepwise logistic regression (LR) analysis was conducted and odds ratios (ORs) calculated to assess associations of satisfaction with questions from the four domains. Fisher's Exact Test was used to determine the association of satisfaction with outcome measures. RESULTS: A final acceptability model was developed based on the following determinants of CVR satisfaction: ease of use, side effects, expulsions/feeling the CVR and sexual activity including physical effects during intercourse. Satisfaction was high (89%) and related to higher method adherence [OR, 2.6 (1.3, 5.2)] and continuation [OR, 5.5 (3.5, 8.4)]. According to the LR analysis, attributes of CVR use representing items from the four domains - finding it easy to remove, not complaining of side effects, not feeling the CVR while wearing it and experiencing no change or an increase in sexual pleasure and/or frequency - were associated with higher odds of satisfaction. CONCLUSION: Hypothesized domains of CVR use were related to satisfaction, which was associated with adherence and continuation. Results provide a scientific basis for introduction and future research. IMPLICATIONS STATEMENT: Acceptability research is important when introducing a new method of contraception and determining whether it can be a successful option in meeting the reproductive health needs of women and men. This study was designed to test a conceptual model of acceptability and identify factors associated with successful use of a new contraceptive delivery modality. Original research was conducted for this publication.
OBJECTIVES: Develop and test a theoretical acceptability model for the Nestorone®/ethinyl estradiol contraceptive vaginal ring (CVR); explore whether domains of use within the model predict satisfaction, method adherence and CVR continuation. STUDY DESIGN: Four domains of use were considered relative to outcome markers of acceptability, that is, method satisfaction, adherence and continuation. A questionnaire to evaluate subjects' experiences relative to the domains, their satisfaction (Likert scale) and adherence to instructions for use was developed and administered to 1036 women enrolled in a 13-cycle Phase 3 trial. Method continuation was documented from the trial database. Stepwise logistic regression (LR) analysis was conducted and odds ratios (ORs) calculated to assess associations of satisfaction with questions from the four domains. Fisher's Exact Test was used to determine the association of satisfaction with outcome measures. RESULTS: A final acceptability model was developed based on the following determinants of CVR satisfaction: ease of use, side effects, expulsions/feeling the CVR and sexual activity including physical effects during intercourse. Satisfaction was high (89%) and related to higher method adherence [OR, 2.6 (1.3, 5.2)] and continuation [OR, 5.5 (3.5, 8.4)]. According to the LR analysis, attributes of CVR use representing items from the four domains - finding it easy to remove, not complaining of side effects, not feeling the CVR while wearing it and experiencing no change or an increase in sexual pleasure and/or frequency - were associated with higher odds of satisfaction. CONCLUSION: Hypothesized domains of CVR use were related to satisfaction, which was associated with adherence and continuation. Results provide a scientific basis for introduction and future research. IMPLICATIONS STATEMENT: Acceptability research is important when introducing a new method of contraception and determining whether it can be a successful option in meeting the reproductive health needs of women and men. This study was designed to test a conceptual model of acceptability and identify factors associated with successful use of a new contraceptive delivery modality. Original research was conducted for this publication.
Authors: Hans-Joachim Ahrendt; Israel Nisand; Carlo Bastianelli; Maria Angeles Gómez; Kristina Gemzell-Danielsson; Wolfgang Urdl; Birgit Karskov; Luc Oeyen; Johannes Bitzer; Geert Page; Ian Milsom Journal: Contraception Date: 2006-09-27 Impact factor: 3.375
Authors: Mitchell D Creinin; Leslie A Meyn; Lynn Borgatta; Kurt Barnhart; Jeff Jensen; Anne E Burke; Carolyn Westhoff; Melissa Gilliam; Caryn Dutton; Susan A Ballagh Journal: Obstet Gynecol Date: 2008-02 Impact factor: 7.661
Authors: Sara E Vargas; Miriam M Midoun; Melissa Guillen; Melissa L Getz; Kristen Underhill; Caroline Kuo; Kate M Guthrie Journal: Perspect Sex Reprod Health Date: 2019-05-20
Authors: Carolina Sales Vieira; Ian S Fraser; Marlena G Plagianos; Anne E Burke; Carolyn L Westhoff; Jeffrey Jensen; Vivian Brache; Luis Bahamondes; Ruth Merkatz; Regine Sitruk-Ware; Diana L Blithe Journal: Contraception Date: 2019-08-06 Impact factor: 3.375
Authors: Kate Morrow Guthrie; Shira Dunsiger; Sara E Vargas; Joseph L Fava; Julia G Shaw; Rochelle K Rosen; Patrick F Kiser; E Milu Kojic; David R Friend; David F Katz Journal: AIDS Res Hum Retroviruses Date: 2016-03-29 Impact factor: 2.205
Authors: Marijn C Verwijs; Stephen Agaba; Marie Michele Umulisa; Mireille Uwineza; Adrien Nivoliez; Elke Lievens; Janneke H H M van de Wijgert Journal: BMJ Open Date: 2020-05-19 Impact factor: 2.692
Authors: Evelyne Kestelyn; Jennifer Ilo Van Nuil; Marie Michelle Umulisa; Grace Umutoni; Alice Uwingabire; Lambert Mwambarangwe; Mireille Uwineza; Stephen Agaba; Tania Crucitti; Janneke van de Wijgert; Thérèse Delvaux Journal: PLoS One Date: 2018-06-18 Impact factor: 3.240
Authors: Melissa J Chen; Mitchell D Creinin; David K Turok; David F Archer; Kurt T Barnhart; Carolyn L Westhoff; Michael A Thomas; Jeffrey T Jensen; Bruce Variano; Regine Sitruk-Ware; Anita Shanker; Jill Long; Diana L Blithe Journal: Contraception Date: 2020-05-19 Impact factor: 3.375
Authors: Yongmei Huang; Ruth B Merkatz; Sharon L Hillier; Kevin Roberts; Diana L Blithe; Régine Sitruk-Ware; Mitchell D Creinin Journal: PLoS One Date: 2015-08-12 Impact factor: 3.240